Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End-use
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Women’s Health Diagnostic Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Women’s Health Diagnostic Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
Chapter 4. Women’s Health Diagnostic: Application Estimates & Trend Analysis
4.1. Women’s Health Diagnostic Market: Key Takeaways
4.2. Women’s Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Cancer
4.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Infectious diseases
4.4.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Osteoporosis
4.5.1. Osteoporosis market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Pregnancy & fertility
4.6.1. Pregnancy & fertility market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Prenatal
4.7.1. Prenatal market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Women’s Health Diagnostic: End-use Estimates & Trend Analysis
5.1. Women’s Health Diagnostic Market: Key Takeaways
5.2. Women’s Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Hospitals
5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Laboratory
5.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Women’s Health Diagnostic Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Women’s Health Diagnostic Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. F. Hoffmann-la Roche Ltd.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Siemens Aktiengeselischaft
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Quest Diagnostics incorporated
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Ge Healthcare
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Koninklijke Philips N.V.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Abbott Laboratories
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Becton, Dickinson and Company
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Hologic, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
Table 1 List of Abbreviations
Table 2 North America women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 3 North America women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 8 Canada women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 10 Europe women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 11 Europe women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 12 Germany women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 13 Germany women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 14 UK women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 15 UK women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 16 France women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 17 France women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 19 Italy women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 21 Spain women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 22 Sweden women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 23 Sweden women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 24 Norway women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 25 Norway women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 27 Denmark women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 31 China women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 32 China women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 33 Japan women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 34 Japan women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 35 India women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 36 India women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 37 Thailand women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 38 Thailand women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 39 South Korea women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 40 South Korea women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 41 Australia women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 42 Australia women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 44 Latin America women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 45 Latin America women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 47 Brazil women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 49 Mexico women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 51 Argentina women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 56 South Africa women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 60 UAE women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 62 Kuwait women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Women’s health diagnostics: market outlook
Fig. 9 Women’s health diagnostics competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Women’s health diagnostics market driver impact
Fig. 15 Women’s health diagnostics market restraint impact
Fig. 16 Women’s health diagnostics market strategic initiatives analysis
Fig. 17 Women’s health diagnostics market: Application movement analysis
Fig. 18 Women’s health diagnostics market: Application outlook and key takeaways
Fig. 19 Cancer market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 20 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 21 Osteoporosis market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 22 Pregnancy & fertility market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 23 Prenatal market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 24 Women’s health diagnostics market: End-use movement analysis
Fig. 25 Women’s health diagnostics market: End-use outlook and key takeaways
Fig. 26 Hospital market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 27 Laboratory market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 28 Homecare market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 30 Global women’s health diagnostics market: Regional movement analysis
Fig. 31 Global women’s health diagnostics market: Regional outlook and key takeaways
Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Millions)
